108 related articles for article (PubMed ID: 20031728)
1. Off-label use and the spectre of drug-eluting stent thrombosis.
Cook S; Wenaweser P
Circ Cardiovasc Interv; 2009 Aug; 2(4):273-6. PubMed ID: 20031728
[No Abstract] [Full Text] [Related]
2. Drug-eluting stent thrombosis in routine clinical practice: two-year outcomes and predictors from the TAXUS ARRIVE registries.
Lasala JM; Cox DA; Dobies D; Baran K; Bachinsky WB; Rogers EW; Breall JA; Lewis DH; Song A; Starzyk RM; Mascioli SR; Dawkins KD; Baim DS;
Circ Cardiovasc Interv; 2009 Aug; 2(4):285-93. PubMed ID: 20031730
[TBL] [Abstract][Full Text] [Related]
3. Stenting unprotected left main: the outcome is not always favorable.
Colombo A
Catheter Cardiovasc Interv; 2008 Mar; 71(4):539-40. PubMed ID: 18307235
[No Abstract] [Full Text] [Related]
4. Which DES for diabetics? Round 1: A draw. Round 2: Everolimus leading?
Hillegass WB
Catheter Cardiovasc Interv; 2010 Jul; 76(1):58-9. PubMed ID: 20578193
[No Abstract] [Full Text] [Related]
5. Recent progress in percutaneous coronary intervention: evolution of the drug-eluting stents, focus on the XIENCE V drug-eluting stent.
Doostzadeh J; Clark LN; Bezenek S; Pierson W; Sood PR; Sudhir K
Coron Artery Dis; 2010 Jan; 21(1):46-56. PubMed ID: 19952925
[TBL] [Abstract][Full Text] [Related]
6. Are we totally clear?
Morrison DA
Catheter Cardiovasc Interv; 2009 Dec; 74(7):987-8. PubMed ID: 19953511
[No Abstract] [Full Text] [Related]
7. Usage patterns and 2-year outcomes with the TAXUS express stent: results of the US ARRIVE 1 registry.
Lasala JM; Cox DA; Dobies D; Muhlestein JB; Katopodis JN; Revtyak G; Baim DS;
Catheter Cardiovasc Interv; 2008 Oct; 72(4):433-45. PubMed ID: 18814217
[TBL] [Abstract][Full Text] [Related]
8. Percutaneous revascularization of the "unprotected" left main during acute myocardial infarction: "Dare to struggle! Dare to win!".
Morrison DA
Catheter Cardiovasc Interv; 2009 Jan; 73(1):22-4. PubMed ID: 19089931
[No Abstract] [Full Text] [Related]
9. Clopidogrel use in diabetic patients with new stents.
Cardiovasc J Afr; 2008; 19(4):232. PubMed ID: 18776976
[No Abstract] [Full Text] [Related]
10. SES for AMI: moving in the right direction.
Vetrovec GW
Catheter Cardiovasc Interv; 2009 Aug; 74(2):333-4. PubMed ID: 19642181
[No Abstract] [Full Text] [Related]
11. Two-stent technique: a dead duck or alive and kicking?
Belardi JA
Catheter Cardiovasc Interv; 2009 Aug; 74(2):321-2. PubMed ID: 19642180
[No Abstract] [Full Text] [Related]
12. "Neither horseshoes nor hand grenades"--does close count in percutaneous coronary revascularization?
Bailey SR
Catheter Cardiovasc Interv; 2008 Oct; 72(4):457-8. PubMed ID: 18819143
[No Abstract] [Full Text] [Related]
13. Inflation time and drug-eluting stent: the longer, the better..
Bertrand OF
Catheter Cardiovasc Interv; 2009 Feb; 73(2):212-3. PubMed ID: 19156881
[No Abstract] [Full Text] [Related]
14. Clinical impact of sirolimus-eluting stent in ST-segment elevation myocardial infarction: a meta-analysis of randomized clinical trials.
Piscione F; Piccolo R; Cassese S; Galasso G; Chiariello M
Catheter Cardiovasc Interv; 2009 Aug; 74(2):323-32. PubMed ID: 19360858
[TBL] [Abstract][Full Text] [Related]
15. Paclitaxel-eluting stents for the treatment of complex coronary lesions: immediate and 12-month results.
Sheiban I; Ballari GP; Moretti C; Marra WG; Meliga E; Omedè P; Sciuto F; Trevi GP
J Cardiovasc Med (Hagerstown); 2007 Aug; 8(8):582-8. PubMed ID: 17667028
[TBL] [Abstract][Full Text] [Related]
16. Drug-eluting stents are associated with similar cardiovascular outcomes when compared to bare metal stents in the setting of acute myocardial infarction.
Slottow TL; Steinberg DH; Roy P; Javaid A; Buch AN; Okabe T; Xue Z; Smith K; Torguson R; Pichard AD; Satler LF; Suddath WO; Kent KM; Waksman R
Cardiovasc Revasc Med; 2008; 9(1):24-8. PubMed ID: 18206634
[TBL] [Abstract][Full Text] [Related]
17. Percutaneous coronary intervention in perspective: drug-eluting stents as a model for regulatory review.
Kandzari DE; Farb A; Boam AB
Circ Cardiovasc Interv; 2009 Dec; 2(6):574-9. PubMed ID: 20031776
[No Abstract] [Full Text] [Related]
18. Evidence-based management of patients undergoing PCI: stent controversies.
Vetrovec GW
Catheter Cardiovasc Interv; 2010 Mar; 75 Suppl 1():S39-42. PubMed ID: 20333706
[TBL] [Abstract][Full Text] [Related]
19. Noncardiac surgery after coronary stenting or angioplasty [corrected] .
Tan WA
Catheter Cardiovasc Interv; 2009 Nov; 74(6):844-5. PubMed ID: 19902506
[No Abstract] [Full Text] [Related]
20. The long-term results of the "Endeavor" stent.
Kornovski R
Catheter Cardiovasc Interv; 2009 Dec; 74(7):996-9. PubMed ID: 19953512
[No Abstract] [Full Text] [Related]
[Next] [New Search]
